## **Core Concept**
The question tests understanding of pharmacological agents that affect aqueous humor dynamics in the eye, specifically those that increase aqueous flow. Aqueous humor is produced by the ciliary body and flows out through the trabecular meshwork, influencing intraocular pressure.

## **Why the Correct Answer is Right**
Prostaglandin analogs, such as **latanoprost**, increase the uveoscleral outflow of aqueous humor. They work by binding to prostaglandin receptors in the ciliary muscle, which increases the permeability of the uveoscleral pathway. This results in a decrease in intraocular pressure, a key treatment goal in glaucoma and ocular hypertension.

## **Why Each Wrong Option is Incorrect**
* **Option A:** Beta-blockers, such as timolol, decrease aqueous humor production but do not increase aqueous flow. They work by blocking beta-adrenergic receptors in the ciliary body, reducing aqueous humor production.
* **Option B:** Alpha agonists, like brimonidine, decrease aqueous humor production and increase uveoscleral outflow but are not primarily known for increasing aqueous flow through the trabecular meshwork.
* **Option C:** Carbonic anhydrase inhibitors, such as acetazolamide, decrease aqueous humor production by inhibiting carbonic anhydrase in the ciliary body, not by increasing aqueous flow.

## **Clinical Pearl / High-Yield Fact**
A key clinical pearl is that prostaglandin analogs are considered first-line treatments for glaucoma due to their efficacy in lowering intraocular pressure by increasing uveoscleral outflow. A classic example is **latanoprost**, which is well-known for this mechanism.

## **Correct Answer:** .